Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunter Wolf

Showing results (121-130 of 314) with videos related to

Pageof 32
Sort By:
Current Drug Targets|February 4, 2006
Kidney diseases and chemokinesUlf Panzer, Oliver M Steinmetz, Rolf A K Stahl, et al.
Patient Education and Counseling|June 11, 2013
Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetesNicolle Müller, Christof Kloos, Alexander Sämann, et al.
Diabetology & Metabolic Syndrome|April 10, 2021
Diabetes related distress is high in inpatients with diabetesNadine Kuniss, Guido Kramer, Ulrich A Müller, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 2, 2019
Association Between Glycaemic Control and the Intake of Thiazide Diuretics, Beta Blockers and Levothyroxine in People Without DiabetesJohannes Roth, Nicole Müller, Nadine Kuniss, et al.
Kidney International|October 22, 2004
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cellsGunter Wolf, Regine Schroeder, Fuad N Ziyadeh, et al.
Nephron. Clinical Practice|April 25, 2008
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertensionMartin Busch, Sybille Franke, Gunter Wolf, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 14, 2017
Reduction of HbA1c and diabetes-related distress after intervention in a diabetes day care clinic in people with type 2 diabetes but not with type 1 diabetesNadine Kuniss, Ulrich Alfons Müller, Christof Kloos, et al.
Pediatric Nephrology (Berlin, Germany)|June 15, 2011
Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Peter F Zipfel, Gunter Wolf, Ulrike John, et al.
European Journal of Radiology|August 15, 2012
Quantitative first pass perfusion in cardiovascular magnetic resonance for determination of peak ventricular transit time--a technique for evaluation of heart functionAndreas Hansch, Jens-Peter Heyne, Christian Jung, et al.
Nephron|August 10, 2016
Vitamin D3 Partly Antagonizes Advanced-Glycation Endproducts-Induced NFκB Activation in Mouse PodocytesChristiane Rüster, Sybille Franke, Stefanie Reuter, et al.
Pageof 32

Showing results (121-130 of 314) with videos related to

Sort By:
Pageof 32
Current Drug Targets|February 4, 2006
Kidney diseases and chemokinesUlf Panzer, Oliver M Steinmetz, Rolf A K Stahl, et al.
Patient Education and Counseling|June 11, 2013
Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetesNicolle Müller, Christof Kloos, Alexander Sämann, et al.
Diabetology & Metabolic Syndrome|April 10, 2021
Diabetes related distress is high in inpatients with diabetesNadine Kuniss, Guido Kramer, Ulrich A Müller, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 2, 2019
Association Between Glycaemic Control and the Intake of Thiazide Diuretics, Beta Blockers and Levothyroxine in People Without DiabetesJohannes Roth, Nicole Müller, Nadine Kuniss, et al.
Kidney International|October 22, 2004
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cellsGunter Wolf, Regine Schroeder, Fuad N Ziyadeh, et al.
Nephron. Clinical Practice|April 25, 2008
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertensionMartin Busch, Sybille Franke, Gunter Wolf, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 14, 2017
Reduction of HbA1c and diabetes-related distress after intervention in a diabetes day care clinic in people with type 2 diabetes but not with type 1 diabetesNadine Kuniss, Ulrich Alfons Müller, Christof Kloos, et al.
Pediatric Nephrology (Berlin, Germany)|June 15, 2011
Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Peter F Zipfel, Gunter Wolf, Ulrike John, et al.
European Journal of Radiology|August 15, 2012
Quantitative first pass perfusion in cardiovascular magnetic resonance for determination of peak ventricular transit time--a technique for evaluation of heart functionAndreas Hansch, Jens-Peter Heyne, Christian Jung, et al.
Nephron|August 10, 2016
Vitamin D3 Partly Antagonizes Advanced-Glycation Endproducts-Induced NFκB Activation in Mouse PodocytesChristiane Rüster, Sybille Franke, Stefanie Reuter, et al.
Pageof 32